Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "Spyre"
showing the first 40- Spyre Therapeutics, Inc. (SYRE)10-Q · 2024-08-07Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2024-05-15Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2025-06-17Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2023-12-08Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)10-Q · 2024-08-07Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)8-K · 2023-09-08Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2024-10-15Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2024-10-15Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)8-K · 2023-06-23Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2023-11-28Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)8-K · 2023-06-22Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)10-Q · 2024-08-07Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2024-03-18Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)10-K · 2025-02-27Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)S-1 · 2023-12-22Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)10-Q · 2023-08-11Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2026-01-12Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2025-06-17Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)8-K · 2023-10-10Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)8-K · 2023-10-24Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)CORRESP · 2023-10-26Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)CORRESP · 2023-11-15Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2025-01-13Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)10-Q · 2024-05-09Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2024-05-09Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)10-Q · 2024-05-09Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2026-01-12Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)S-8 · 2023-12-22Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)S-1/A · 2023-10-10Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2026-06-15Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2026-06-01Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2025-11-04Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2024-11-12Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2026-08-04Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)10-K/A · 2024-03-01Read the filing on SEC.gov →
- Aeglea BioTherapeutics, Inc. (SYRE)8-K · 2023-10-05Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2024-11-12Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)8-K · 2026-04-13Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)10-Q/A · 2024-11-18Read the filing on SEC.gov →
- Spyre Therapeutics, Inc. (SYRE)D · 2023-12-27Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.